Korro Bio Inc. (KRRO)
34.15
0.80 (2.40%)
At close: Jan 30, 2025, 1:12 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -81.17M | -58.03M | -21.96M | -26.51M | -18.75M | -19.17M | -20.24M |
| Depreciation & Amortization | 3.63M | 2.51M | 1.59M | 1.58M | 813.00K | 654.00K | 531.00K |
| Stock-Based Compensation | 2.38M | 1.14M | 807.00K | n/a | n/a | n/a | n/a |
| Other Working Capital | 1.18M | -2.39M | 848.00K | -34.53M | 49.29M | 819.00K | 276.00K |
| Other Non-Cash Items | 3.61M | 1.51M | -13.47M | 8.86M | 5.77M | 1.98M | 5.88M |
| Deferred Income Tax | -15.00K | -145.00K | 28.00K | n/a | n/a | n/a | n/a |
| Change in Working Capital | 4.28M | -633.00K | 904.00K | -30.24M | 48.65M | 819.00K | 276.00K |
| Operating Cash Flow | -67.28M | -53.65M | -32.09M | -45.19M | 34.22M | -17.02M | -14.61M |
| Capital Expenditures | -7.84M | -5.21M | -4.45M | -6.67M | -1.06M | -436.00K | -1.86M |
| Acquisitions | n/a | n/a | -29.23M | n/a | n/a | 3.77M | n/a |
| Purchase of Investments | n/a | -37.21M | -35.07M | -26.34M | -282.62M | n/a | n/a |
| Sales Maturities Of Investments | 19.00M | 53.48M | 29.23M | 43.42M | 265.42M | n/a | n/a |
| Other Investing Acitivies | n/a | 16.27K | 13.00K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 11.16M | 11.06M | -39.50M | 10.40M | -18.26M | 3.34M | -1.86M |
| Debt Repayment | n/a | n/a | n/a | 15.00M | n/a | 5.00M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 69.81M | 18.00K | 115.94M | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 187.76M | 18.00K | 115.94M | 56.69M | 142.01M | 37.94M | 27.98M |
| Net Cash Flow | 131.64M | -42.57M | 44.35M | 20.18M | 157.97M | 24.25M | 11.50M |
| Free Cash Flow | -75.12M | -58.86M | -36.54M | -51.86M | 33.15M | -17.46M | -16.48M |